| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advantages of a larger working channel diameter of ultrathin bronchoscope in cone-beam computed tomography-guided transbronchial biopsy for diagnosing peripheral lung lesions
|
Kawakita, Naoya
|
|
|
202 |
C |
p.
|
artikel
|
| 2 |
ALK-EML4 Fusion in Small Cell Lung Cancer: Clinical and Molecular Insights From a Rare Case
|
Jaber, Ghina
|
|
|
202 |
C |
p.
|
artikel
|
| 3 |
A phase 1b study of cofetuzumab pelidotin monotherapy in patients with PTK7-expressing recurrent non-small cell lung cancer
|
Cho, Byoung Chul
|
|
|
202 |
C |
p.
|
artikel
|
| 4 |
A randomised non-comparative phase II study of atezolizumab, bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance – The ETOP 15-19 ABC-lung trial
|
Soo, R.A.
|
|
|
202 |
C |
p.
|
artikel
|
| 5 |
Clinical characteristics and management of long survivors in extensive stage small cell lung cancer
|
Gobbini, Elisa
|
|
|
202 |
C |
p.
|
artikel
|
| 6 |
Commentary on: Identification of key gene signatures for predicting chemo-immunotherapy efficacy in extensive-stage small-cell lung cancer using machine learning
|
Triwiyanto, T.
|
|
|
202 |
C |
p.
|
artikel
|
| 7 |
Contents
|
|
|
|
202 |
C |
p.
|
artikel
|
| 8 |
CRES3T: A single-arm confirmatory trial of S-1 plus cisplatin with concurrent radical-dose radiotherapy followed by surgery for superior sulcus tumors
|
Takamochi, Kazuya
|
|
|
202 |
C |
p.
|
artikel
|
| 9 |
Efficacy of antiangiogenic therapy in patients with advanced SMARCA4-deficient thoracic tumor
|
Shi, Mengting
|
|
|
202 |
C |
p.
|
artikel
|
| 10 |
Efficacy of EGFR tyrosine kinase inhibitors in patients with non–small cell lung cancer with EGFR exon 19 insertions: clinical-genomic, preclinical analysis through LC-SCRUM-Asia (multi-institutional genomic screening registry)
|
Uehara, Yuji
|
|
|
202 |
C |
p.
|
artikel
|
| 11 |
EGFR mutation status affects intra-tumoural heterogeneity of PD-L1 expression but not agreement between assays in resectable non-small cell lung cancer
|
Saw, Stephanie P.L.
|
|
|
202 |
C |
p.
|
artikel
|
| 12 |
Establishing survival benchmarks in the era of peri-operative immunotherapy
|
Gallina, Filippo Tommaso
|
|
|
202 |
C |
p.
|
artikel
|
| 13 |
Evaluating the prognostic impact of EGFR mutation on adjuvant chemotherapy efficacy in grade 3 stage IB lung adenocarcinoma
|
An, Zhao
|
|
|
202 |
C |
p.
|
artikel
|
| 14 |
Evaluation of teleguided high-intensity exercise rehabilitation at home before lung-cancer surgery (PREPACHIR Study)
|
Vinas, Florent
|
|
|
202 |
C |
p.
|
artikel
|
| 15 |
Evolving treatments and prognosis in Stage IV non-small cell lung cancer: 20 years of progress of novel therapies
|
Satoh, Hironori
|
|
|
202 |
C |
p.
|
artikel
|
| 16 |
Exclusive radiologically determined myopenia does not equate to sarcopenia
|
Topkan, Erkan
|
|
|
202 |
C |
p.
|
artikel
|
| 17 |
Feasibility and safety of perioperative entrectinib in a patient with ROS1-positive locally advanced NSCLC: A case report
|
Fan, Mengying
|
|
|
202 |
C |
p.
|
artikel
|
| 18 |
From data to prediction: Digital chest drain insights into postoperative recovery after lung cancer surgery
|
Verkoulen, Koen C.H.A.
|
|
|
202 |
C |
p.
|
artikel
|
| 19 |
Gefitinib for EGFR mutated lung adenocarcinoma during pregnancy: A case report with 5-Year Follow-Up
|
Messekher, Merouane
|
|
|
202 |
C |
p.
|
artikel
|
| 20 |
Identifying and exploring patient engagement interventions for people diagnosed with lung cancer: A rapid systematic review
|
Cooke, S.
|
|
|
202 |
C |
p.
|
artikel
|
| 21 |
Immunotherapy in advanced non-small cell lung cancer: What to do for the ‘Invisible’ patients after IPSOS trial results?
|
Gridelli, Cesare
|
|
|
202 |
C |
p.
|
artikel
|
| 22 |
Implications of EGFR expression on EGFR signaling dependency and adaptive immunity against EGFR-mutated lung adenocarcinoma
|
Torasawa, Masahiro
|
|
|
202 |
C |
p.
|
artikel
|
| 23 |
Letter: Alectinib combined with cobimetinib in ALK-rearranged lung cancer: A phase IB study
|
Naveed, Fatima
|
|
|
202 |
C |
p.
|
artikel
|
| 24 |
Lung cancer risk between maternal and paternal half-siblings points to main environmental causation and targets for prevention
|
Hemminki, Kari
|
|
|
202 |
C |
p.
|
artikel
|
| 25 |
National clinical practice patterns of uniportal video-assisted thoracoscopic anatomical lung resections: nationwide population-based data from a clinical audit registry
|
Laven, Iris E.W.G.
|
|
|
202 |
C |
p.
|
artikel
|
| 26 |
Osimertinib long-term tolerability in patients with EGFRm NSCLC enrolled in the AURA program or FLAURA study
|
Garassino, Marina Chiara
|
|
|
202 |
C |
p.
|
artikel
|
| 27 |
Pathological & radiological variables in the diagnosis of bronchopulmonary carcinoids (BPCs) with a focus on Antigen Kiel 67 (Ki-67) proliferation index
|
Ahuja, Gaurav
|
|
|
202 |
C |
p.
|
artikel
|
| 28 |
Patterns and preoperative risk factors of occult lymph node metastasis in clinical stage I lung cancer
|
Yang, Young Ho
|
|
|
202 |
C |
p.
|
artikel
|
| 29 |
Precision projections of the delay of resistance mutations in non-small cell lung cancer via suppression of APOBEC
|
Nousias, Orestis
|
|
|
202 |
C |
p.
|
artikel
|
| 30 |
Prospective cohort study of Suture-Line recurrence and clinical outcomes in stage 1A Non-Small cell lung cancer
|
Gros, Louis
|
|
|
202 |
C |
p.
|
artikel
|
| 31 |
Reassessing pembrolizumab dosing in NSCLC for methodological and clinical accuracy – Author’s reply
|
Grit, Geeske F.
|
|
|
202 |
C |
p.
|
artikel
|
| 32 |
Redefining resectability: Bridging perspectives in stage III NSCLC management
|
Bertolaccini, Luca
|
|
|
202 |
C |
p.
|
artikel
|
| 33 |
Sex disparities in advanced non-small cell lung cancer survival: A Danish nationwide study
|
Frost, Matilde Grupe
|
|
|
202 |
C |
p.
|
artikel
|
| 34 |
The diagnostic value of comprehensive next-generation sequencing for genetic mutations in suspected lung cancer cases with negative pathological cytology
|
Goto, Yuka
|
|
|
202 |
C |
p.
|
artikel
|
| 35 |
Two-year survival and disease recurrence after endosonography with or without confirmatory mediastinoscopy for resectable lung cancer (a short communication of the MEDIASTrial follow-up)
|
Bousema, Jelle E.
|
|
|
202 |
C |
p.
|
artikel
|
| 36 |
Use of immune checkpoint inhibitors in patients with lung cancer and multiple sclerosis
|
Iglesias Martinez, Belén
|
|
|
202 |
C |
p.
|
artikel
|
Tijdschrift beschrijving